BiomX Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
PHGE on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
22 Einstein St., Floor 4, Ness Ziona, Israel

Insiders trading volume in the past year

BiomX Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James E. Flynn Director, *Director by Deputization $6.81M Jul 15, 2024
OrbiMed Israel BioFund GP Limited Partnership 10%+ Owner $5.25M -$9.28K -0.18% May 15, 2024
Chidozie Ugwumba Exit Form 4 - former 10% owner $1.02M Oct 17, 2022
Jonathan Solomon Chief Executive Officer, Director $20.2K Sep 16, 2024
Merav Bassan Chief Development Officer $12.1K Sep 16, 2024
Assaf Oron Chief Business Officer $9.84K Sep 16, 2024
Paul J. Sekhri Director $4.25K Jul 28, 2021
Alan Moses Director Jul 11, 2024
Gbolahan Amusa Director Mar 29, 2022
Russell Greig Director Jul 11, 2024
Marina Wolfson Chief Financial Officer Jul 11, 2024
Thomas Layton Walton 10%+ Owner Dec 31, 2021
Dambach Michael E. Director Aug 21, 2023
Marks Jason M. Director Aug 21, 2023
Jonas Grossman Director Mar 29, 2022
Susan Blum Director Jul 11, 2024
Avraham Gabay Interim CFO Dec 6, 2023
Jesse Goodman Director Jul 11, 2024
Cystic Fibrosis Foundation 10%+ Owner May 15, 2024
Gregory Merril Director Jul 11, 2024
Jonathan Leff Director Jul 11, 2024
Eddie Williams Director Jul 11, 2024
Lynne Sullivan Director Mar 1, 2023

Recent Insider Transactions by Companies or Individuals for BiomX Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.